[HTML][HTML] Engineered CAR-macrophages as adoptive immunotherapies for solid tumors

C Sloas, S Gill, M Klichinsky - Frontiers in immunology, 2021 - frontiersin.org
… nature of macrophage polarization (17, 18); here, we provide a brief overview … macrophage
phenotype for the context of solid tumor therapies. “Classically activated” (M1) macrophages

[HTML][HTML] CAR-macrophage: A new immunotherapy candidate against solid tumors

Y Chen, Z Yu, X Tan, H Jiang, Z Xu, Y Fang… - Biomedicine & …, 2021 - Elsevier
tumor invasion, and mediate immunosuppression. Because macrophages can infiltrate solid
tumor … cellular components in the tumor microenvironment (including tumor cells, immune …

[HTML][HTML] Advancing CAR-based immunotherapies in solid tumors: CAR-macrophages and neutrophils

Y Liang, Q Xu, Q Gao - Frontiers in Immunology, 2023 - frontiersin.org
… , and designs of CAR-engineered macrophages (CAR-Ms) and neutrophils (CAR-Ns), their
… research directions for the broader applications of CAR-Ms and CAR-Ns in solid tumors. …

[HTML][HTML] The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors

K Hadiloo, S Taremi, M Heidari, A Esmaeilzadeh - Biomarker Research, 2023 - Springer
… of solid tumors. In this review, we explained the macrophage cell and their roles in TME,
correlation between the CAR structure and these cells, compared CAR M cells to other …

Targeting macrophages with CAR T cells delays solid tumor progression and enhances antitumor immunity

AR Sánchez-Paulete, J Mateus-Tique… - Cancer immunology …, 2022 - AACR
… the development of a strategy for TAM depletion in mouse solid tumor models using chimeric
antigen receptor (CAR) T cells targeting the macrophage marker F4/80 (F4.CAR-T). F4.…

[HTML][HTML] M1 polarization enhances the antitumor activity of chimeric antigen receptor macrophages in solid tumors

Y Huo, H Zhang, L Sa, W Zheng, Y He, H Lyu… - Journal of Translational …, 2023 - Springer
CAR-M therapy has shown unique and impressive antitumor effects in … for solid tumors.
However, the polarization state of macrophages can affect the antitumor effect of CAR-M. We …

[HTML][HTML] CARs and beyond: tailoring macrophage-based cell therapeutics to combat solid malignancies

SM Abdin, D Paasch, M Morgan… - … for Immunotherapy of …, 2021 - ncbi.nlm.nih.gov
… in macrophages may widen the spectrum of CAR applications for better control of solid tumors
… Given the novel insights into tumor-associated macrophages and new targeting strategies …

[HTML][HTML] CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy

K Pan, H Farrukh, VCSR Chittepu, H Xu, C Pan… - Journal of Experimental …, 2022 - Springer
… Consequently, there is significant interest in developing CAR macrophages for … with CAR
T/NK therapy, especially in solid tumors. Nevertheless, both CAR NK and CAR macrophages

[HTML][HTML] CAR-macrophage versus CAR-T for solid tumors: The race between a rising star and a superstar

K Chen, M Liu, J Wang, S Fang - Biomolecules and Biomedicine, 2024 - ncbi.nlm.nih.gov
… , challenges faced in treating solid tumors, and insights gleaned … solid tumors. We especially
highlight the potential advantages of CAR-macrophage therapy over CAR-T for solid tumors

[HTML][HTML] Targeting macrophages: a novel treatment strategy in solid tumors

M Liu, L Liu, Y Song, W Li, L Xu - Journal of Translational Medicine, 2022 - Springer
… receptor macrophages (CAR-Ms) may provide even greater benefit for patients with solid
tumors. In this review, we discuss how TAMs promote the progression of solid tumors as well as …